Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BBOT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BBOT, solid
LLY, dashed
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.22
▲
+2.52%
Mkt cap
$173.7M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,368.38
▲
+0.27%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
2.22
▲
+2.52%
Price
1,368.38
▲
+0.27%
$173.7M
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
BBOT
2.22
▲
+2.52%
vs
LLY
1,368.38
▲
+0.27%
Regular session
Nov 6 '26